Related Experiment Video
Updated: May 30, 2025
05:33
High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines
Published on: November 9, 2020
9.4K
[Exploring protein degradation pathways as therapeutic innovations]
Marie Cornu1, Thomas Lemaitre1, Florian Schwalen2
1Université de Caen Normandie, CERMN UR4258, Boulevard Becquerel, 14000 Caen, France.
Biologie Aujourd'Hui
|January 27, 2025
Summary
Proteostasis disruption creates opportunities for new therapies like Proteolysis Targeting Chimeras (PROTACs). PROTACs selectively degrade disease-causing proteins, offering hope for treating cancers and neurodegenerative diseases.
Area of Science:
- Biochemistry
- Molecular Biology
- Drug Discovery
Background:
- Proteostasis, or protein homeostasis, is crucial for cellular function.
- Disrupted proteostasis is implicated in various diseases, including cancer and neurodegenerative disorders.
- Conventional therapies face challenges in targeting specific disease-associated proteins.
Purpose of the Study:
- To explore the therapeutic potential of Proteolysis Targeting Chimeras (PROTACs).
- To investigate how PROTACs can address limitations of traditional treatment strategies.
- To highlight PROTACs as a tool for restoring protein homeostasis.
Main Methods:
- Utilizing Proteolysis Targeting Chimeras (PROTACs) technology.
- Inducing targeted protein degradation via the ubiquitin-proteasome system.
- Applying PROTACs to disease models involving protein homeostasis disruption.
Main Results:
- PROTACs enable selective degradation of disease-relevant proteins.
- This approach offers new therapeutic avenues for previously untreatable conditions.
- PROTACs can overcome resistance mechanisms associated with conventional drugs.
Conclusions:
- PROTAC technology represents a significant therapeutic innovation.
- Targeted protein degradation by PROTACs can restore proteostasis.
- PROTACs provide a promising strategy for treating complex diseases like cancer and neurodegeneration.
Related Concept Videos
02:58Regulated Protein Degradation
2.5K
2.5K
01:13The Proteasome
803
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
803
02:26Protein Networks
3.9K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
3.9K
02:11Proteins: From Genes to Degradation
11.9K
Within a biological system, the DNA encodes the RNA, and the nucleotide sequence in the RNA further defines the amino acid sequence in the protein. This is referred to as “The Central Dogma of Molecular Biology” - a term coined by Francis Crick. Central dogma is a firm principle in biology that defines the flow of genetic information within any life form. The two fundamental steps in central dogma are - transcription and translation.
Transcription is the synthesis of RNA...
Transcription is the synthesis of RNA...
11.9K
01:32Export of Misfolded Proteins out of the ER
3.5K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.5K
02:04Protein-protein Interfaces
12.4K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.4K